Treatment of Adults With Growth Hormone Deficiency
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The objective of this rollover study is to evaluate the long term (1 year) safety of a new
weekly administered growth hormone preparation in adults with growth hormone deficiency who
were treated with the same experimental preparation in study BPLG-005. In addition, further
change in efficacy endpoints of BPLG-005 by prolonged treatment will be evaluated. Additional
efficacy and safety data of the experimental preparation will be obtained from the
switch-over patients.